Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/23/2003CA2480512A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/23/2003CA2480213A1 Use of interleukin-19 to treat ovarian cancer
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2480079A1 Antiangiogenic active immunotherapy
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/23/2003CA2479519A1 Use of interleukin-19 to treat cervical cancer
10/23/2003CA2466301A1 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355025A2 Anti-panic opening system for doors
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354952A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354947A1 Novel polypeptide
10/22/2003EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide
10/22/2003EP1354893A2 Physiologically active complex
10/22/2003EP1354892A1 Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it
10/22/2003EP1354599A2 Pharmaceutical or food composition for treating pathologies related to graft versus host
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354597A2 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354580A1 Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
10/22/2003EP1354208A2 Methods of diagnosis and treatment of osteoporosis
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354054A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/22/2003EP1354045A2 Hyperglycosylated polypeptides
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354038A2 Double-stranded rna-mediated gene suppression
10/22/2003EP1354033A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353968A1 Linear block polymer
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353951A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
10/22/2003EP1353948A2 Soluble cyclic analogues of the beta amyloide peptide
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353944A2 Methods of investigating, diagnosing, and treating amyloidosis
10/22/2003EP1353942A2 Peptide inhibitors of hiv entry
10/22/2003EP1353940A2 Methods for producing and improving therapeutic potency of binding polypeptides
10/22/2003EP1353939A2 Tetrapeptide regulating prostate functions and its compositions and methods
10/22/2003EP1353937A2 Specific human antibodies for selective cancer therapy
10/22/2003EP1353935A2 Selection of catalytic nucleic acids targeted to infectious agents
10/22/2003EP1353929A2 Streptogramin derivatives preparation thereof and compositions containing same
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353727A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
10/22/2003EP1353702A2 Genetic engineering of vascular grafts to resist disease
10/22/2003EP1353701A2 Methods and compositions for enhanced delivery of bioactive molecules
10/22/2003EP1353698A1 Recombinant serum albumin for use in cleansing or dermatological products for skin or hair
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353696A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
10/22/2003EP1353685A2 Controlled release pharmaceutical systems
10/22/2003EP1353684A2 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1353680A2 Use of slpi for treating chronic inflammatory intestinal diseases
10/22/2003EP1353648A2 Microparticles of biodegradable polymer encapsulating a biologically active substance
10/22/2003EP1353622A2 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
10/22/2003EP1353555A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
10/22/2003EP1204676B1 Streptogramin derivatives, preparation and compositions containing same
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP1003860B1 Modified dorsal tissue affecting factor and compositions
10/22/2003EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451044A Neutrokine－α和Neutrokine－α剪接变体 Neutrokine-α and Neutrokine-α splice variants
10/22/2003CN1451017A Selective cyclic peptides
10/22/2003CN1451016A Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1450915A Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450908A Neurotoxic oligomers
10/22/2003CN1450892A Mesoprogestins (progesterone receptor modulators) for treatment and prevention of hormone dependent gynecological
10/22/2003CN1450239A Emergency door opening system
10/22/2003CN1450083A Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents
10/22/2003CN1449823A Use of ulinastatin in treating SARS and medicinal composition thereof
10/22/2003CN1449822A New use of gene recombinant human lysozyme in pharmacy for curing coronal virus of SARS
10/22/2003CN1449821A Stable recombination human alpha interferon liquid preparation and productive process thereof
10/22/2003CN1449820A Interferon lozenge ice block and making method and use thereof
10/22/2003CN1449819A Weishengli oral liquid medicine and preparation process thereof
10/22/2003CN1449748A Dry powder microsphere inhalant for lung and preparation process thereof
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125081C Recombined natural and new-type human insulin and its preparation
1 ... 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 ... 3163